DGAP-News: Eckert & Ziegler: Extraordinary General Shareholders' Meeting Approves Merger with Eckert & Ziegler BEBIG SA. Change in the Supervisory Board.


 

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Merger/Change of Personnel
Eckert & Ziegler: Extraordinary General Shareholders' Meeting Approves Merger with Eckert & Ziegler BEBIG SA. Change in the Supervisory Board.

20.12.2018 / 14:35
The issuer is solely responsible for the content of this announcement.


Berlin, 20 December 2018. The Extraordinary General Shareholders' Meeting of Eckert & Ziegler Strahlen- und Medizintechnik AG today approved the merger between Eckert & Ziegler Strahlen- und Medizintechnik AG as absorbing company with the Belgian Eckert & Ziegler BEBIG SA as absorbed company. The resolution has been taken with 99,95 % of the votes.

Change in the Supervisory Board
Dr Edgar Loeffler, medical physicist and former member of the Executive Board will join the Supervisory Board as of January1, 2019. Dr Loeffler has been elected as substitute member of the Supervisory Board by the Annual General Shareholder's Meeting in May 2018. He will follow Dr. Gudrun Erzgraeber, radiobiologist, who is withdrawing from the Supervisory Board with effect from the end of December 2018. At the same date Hans-Joerg Hinke, who also steps down from the Supervisory Board, is to hand over his position to Jutta Ludwig. Jutta Ludwig, a Hamburg based China expert, will help expand the Group's Asian business trough her expertise and network. The Supervisory Board and Executive Board thank both leaving members for their many years of service and their commitment to Eckert & Ziegler.

About Eckert & Ziegler.
Eckert & Ziegler Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with around 800 employees, is one of the world's largest providers of isotope-related components for radiation therapy and nuclear medicine.
Contributing to saving lives.

Contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com



20.12.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange

 
End of News DGAP News Service

760995  20.12.2018 

fncls.ssp?fn=show_t_gif&application_id=760995&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2012 2013 2014 2015 2016 2017 2018 2019e
Umsatzerlöse1 120,00 117,14 127,26 139,75 137,94 138,63 168,71 180,00
EBITDA1,2 27,48 22,07 20,10 26,98 24,97 26,62 32,14 32,30
EBITDA-Marge3 22,90 18,84 15,79 19,31 18,10 19,20 19,05 17,94
EBIT1,4 19,73 12,82 12,96 18,22 16,23 17,97 23,39 23,50
EBIT-Marge5 16,44 10,94 10,18 13,04 11,77 12,96 13,86 13,06
Jahresüberschuss1 10,29 9,09 6,50 10,37 9,79 15,12 16,89 19,00
Netto-Marge6 8,58 7,76 5,11 7,42 7,10 10,91 10,01 10,56
Cashflow1,7 16,57 14,65 10,65 16,23 19,83 26,83 21,21 22,50
Ergebnis je Aktie8 1,95 1,72 1,28 2.03 1,81 2,78 3,12 4,10
Dividende8 0,60 0,60 0,60 0,60 0,66 0,80 1,20 1,40
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2018 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Eckert & Ziegler
WKN Kurs in € Einschätzung Börsenwert in Mio. €
565970 188,000 Halten 995,08
KGV 2020e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
44,76 17,26 2,654 94,00
KBV KCV KUV EV/EBITDA
7,66 46,92 5,90 29,695
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
Hauptversammlung
1,40 1,40 0,74 17.06.2020
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
12.05.2020 13.08.2020 12.11.2019 31.03.2020
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
12,41% 51,19% 204,70% 181,86%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Eckert & Ziegler Strahlen- und Medizintechnik AG  ISIN: DE0005659700 können Sie bei DGAP abrufen

Medtech , 565970 , EUZ , XETR:EUZ